Literature DB >> 8186700

Myotonic dystrophy: over-expression or/and under-expression? A critical review on a controversial point.

H Hofmann-Radvanyi1, C Junien.   

Abstract

Myotonic dystrophy (DM) results from the amplification of an unstable (CTG)n sequence in the 3' untranslated region of the myotonin-protein kinase (MT-PK) gene. The expression of the enlarged allele in DM patients with a number of repeats below or beyond 200, was analysed by three different groups. Two groups showed a decreased or absent expression of mutant alleles in DM adults, in congenitally affected infants (CDM) and in an affected fetus. On the contrary, another group reported the increased expression of the mutated allele in several tissues of a CDM infant. These discrepancies may be explained by the different methods used, the small number of patients, the individuals and tissues used as controls, or reflect the use of primers located in different regions of the MT-PK gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8186700     DOI: 10.1016/0960-8966(93)90104-r

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  6 in total

1.  Novel isoform of myotonin protein kinase: gene product of myotonic dystrophy is localized in the sarcoplasmic reticulum of skeletal muscle.

Authors:  M Shimokawa; S Ishiura; N Kameda; M Yamamoto; N Sasagawa; N Saitoh; H Sorimachi; H Ueda; S Ohno; K Suzuki; T Kobayashi
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

2.  Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy.

Authors:  L T Timchenko; J W Miller; N A Timchenko; D R DeVore; K V Datar; L Lin; R Roberts; C T Caskey; M S Swanson
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

Review 3.  Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases.

Authors:  Lise Barbé; Steve Finkbeiner
Journal:  Front Aging Neurosci       Date:  2022-05-03       Impact factor: 5.702

Review 4.  Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.

Authors:  Zhihua Gao; Thomas A Cooper
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

5.  Full-length myotonin protein kinase (72 kDa) displays serine kinase activity.

Authors:  L Timchenko; W Nastainczyk; T Schneider; B Patel; F Hofmann; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

6.  In vivo assessment of muscle membrane properties in myotonic dystrophy.

Authors:  S Veronica Tan; Werner J Z'graggen; Delphine Boërio; Christopher Turner; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2016-05-24       Impact factor: 3.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.